Sandra Levy
ARTICLES BY THIS AUTHOR
- 1/12/2020
Upsher-Smith debuts generic Haldol
Haloperidol tablets had a market value of approximately $41 million for the 12 months ended August 2019, according to IQVIA. - 1/9/2020
PerceptiMed's scripClip will-call automation available to PBA Health members
PerceptiMed’s scripClip will-call automation system will be available to 3,000 PBA Health member pharmacy locations. - 1/9/2020
Upsher-Smith debuts generic Luvox
Fluvoxamine tablets had a market value of approximately $28 million for the 12 months ended September 2019. - 1/8/2020
MedCerts retools pharmacy technician training to align with ASHP/ACPE updates
The MedCerts newly enhanced program now features expanded customer service training, which has been identified by employers as the most in demand “soft skills” for technicians. - 1/8/2020
Innovation introduces new leadership team
Innovation has announced its new leadership on the heels of the recent closing of the transaction in which a consortium of investors, led by Greg Wasson, the former Walgreens Boots Alliance CEO, acquired a majority stake in the company. - 1/8/2020
FlavoRx adds 2 corporate vice presidents
FlavoRx has hired two industry veterans in the wake of growth from its Fillmaster Auto dispensing technology. - 1/7/2020
Pharmacists continue to top annual Gallup Poll as trustworthy professionals
On the heels of Gallup's finding that pharmacists are highly valued, NACDS urges fair reimbursement and better access to pharmacy care. - 1/7/2020
NACDS to HHS inspector general: Pharmacies are essential to value-based care
In comments to the Department of Health and Human Services, NACDS said that pharmacies should be included in the definition of value-based enterprise. - 1/6/2020
Schnucks kicks off community-wide step challenge
Schnucks customers who log 50,000 steps or more now through Feb. 29 have a chance to win $100. - 1/6/2020
Alembic launches generic Temovate
Alembic's generic Temovate provides a short-term topical treatment of inflammatory and pruritic manifestations of moderate to severe corticosteroid-responsive dermatoses of the scalp.
